NX-13 is a novel oral small molecule NLRX1 agonist, which can increase oxidative phosphorylation in immune cells, decrease the differentiation of effector CD4+ T cells, and reduce the production of inflammatory cytokines in the gastrointestinal tract through activation of the NLRX1 pathway, and can be used in studies related to ulcerative colitis (UC).
Molekulargewicht:
399.44
Reinheit:
>98.0%
CAS Nummer:
[2389235-01-0]
Formel:
C24H21N3O3
Target-Kategorie:
NLR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten